Summary
The provided label text appears unrelated to amoxicillin/clavulanate (appears to be for potassium citrate). No FDA-approved prescribing information for amoxicillin potassium/clavulanate is available in the prompt, so none of the extracted drug claims can be verified against the label.
Category Scores
Accurate Statements
Unsupported Statements
Amoxycillin potassium clavulanate tablets are a combined antibiotic.
Not supported by the provided label text (which contains potassium citrate contraindications/description, not amoxicillin/clavulanate).
Amoxycillin potassium clavulanate is used to treat certain bacterial infections where bacteria may be resistant to amoxycillin alone.
No INDICATIONS/USAGE content for amoxicillin/clavulanate is included in the provided label sections.
Amoxycillin in the combination is a penicillin-type antibiotic.
No composition/description information for amoxicillin/clavulanate is included in the provided label sections.
Clavulanic acid in the combination is a beta-lactamase inhibitor.
No clavulanic acid/beta-lactamase inhibitor information is included in the provided label sections.
Clavulanic acid helps amoxycillin work against some resistant bacteria.
No mechanism/clinical pharmacology for amoxicillin/clavulanate is included in the provided label sections.
Amoxycillin potassium clavulanate is commonly prescribed for infections involving the sinuses.
No approved indication or usage-frequency statements for amoxicillin/clavulanate are included.
Amoxycillin potassium clavulanate is commonly prescribed for infections involving the ears.
No label support for ear-related infection usage/frequency is included.
Amoxycillin potassium clavulanate is commonly prescribed for infections involving the teeth.
No label support for dental/tooth-related infection usage/frequency is included.
Amoxycillin potassium clavulanate is commonly prescribed for some respiratory infections.
No label support for respiratory infection usage/frequency is included.
Amoxycillin potassium clavulanate is commonly prescribed for some skin/soft-tissue infections.
No label support for skin/soft-tissue infection usage/frequency is included.
Dosing depends on the infection type, severity, and patient factors, especially age and kidney function.
No amoxicillin/clavulanate dosing or renal adjustment information is included in the provided label sections.
Clinicians tailor the regimen and tablet strength to the target bacteria and treatment duration.
No amoxicillin/clavulanate dosage selection/titration language is included in the provided label sections.
Patients should follow the prescription label exactly and not adjust the dose without a prescriber.
No patient counseling or dosing instructions for amoxicillin/clavulanate are included.
Common side effects include gastrointestinal upset such as nausea, vomiting, diarrhea, and stomach discomfort.
Adverse reaction content for amoxicillin/clavulanate is not provided in the available label text (provided adverse reactions section content is empty/unrelated).
Rash can occur as a side effect.
No rash/dermatologic adverse reaction information for amoxicillin/clavulanate is included.
A severe allergic reaction may occur, with examples including facial swelling and breathing difficulty.
No hypersensitivity/anaphylaxis warning content for amoxicillin/clavulanate is included in the provided label sections.
Antibiotics can sometimes cause serious intestinal side effects, including severe diarrhea, especially if watery or with blood.
No antibiotic-associated colitis/serious diarrhea precaution language for amoxicillin/clavulanate is included.
If a dose is missed, it should be taken when remembered unless it is close to the next scheduled dose.
No missed-dose instruction for amoxicillin/clavulanate is included.
Patients should not take a double dose to make up for a missed tablet.
No missed-dose/double-dose counseling for amoxicillin/clavulanate is included.
Extra caution is needed with a history of penicillin or other beta-lactam allergy.
No beta-lactam allergy precaution is included in the provided label text.
Extra caution is needed with significant kidney problems because dose adjustments are often required.
No amoxicillin/clavulanate renal dosing/adjustment information is included.
Extra caution is needed with a history of antibiotic-associated colitis or severe diarrhea.
No antibiotic-associated colitis precaution language for amoxicillin/clavulanate is included.
“Amoxycillin potassium clavulanate tablets IP” indicates the medicine meets Indian Pharmacopoeia (IP) standards.
No label support for IP standard claims for amoxicillin/clavulanate is included; the provided description relates to potassium citrate USP.
Brand names may differ by manufacturer, but the active ingredients and tablet strength should match the generic specification.
No label support for brand-name/generic-equivalence statements is included.
Contradictions
Important Omissions
FDA-approved prescribing information for amoxicillin potassium/clavulanate (indications, dosage & administration, contraindications, boxed warnings, warnings/precautions, drug interactions, adverse reactions, and special populations) is not present in the provided label text, so label-critical safety and dosing details cannot be evaluated or confirmed.
Importance:
High
Safety Assessment
Potential Patient Risk:
High
Because the underlying FDA-approved label content for amoxicillin/clavulanate is not provided (the available label text appears unrelated), multiple specific clinical, dosing, and safety claims are unsupported; this could lead to inaccurate patient information.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
High |
Recommendation
Noncompliant
Primary Issue
No FDA-approved label content for amoxicillin potassium/clavulanate was provided; all extracted claims are unsupported by the available label text.
Suggested Improvement
Provide the actual FDA-approved prescribing information sections for amoxicillin potassium/clavulanate tablets (Indications/Usage, Dosage/Administration, Contraindications, Warnings/Precautions, Drug Interactions, Adverse Reactions, and Special Populations) so claims can be verified and any material omissions corrected.